Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma.

Autor: Feng, Demei1 (AUTHOR), Yan, Zhimin2 (AUTHOR), Fu, Bibo1 (AUTHOR), Bai, Shenrui1 (AUTHOR), Zhu, Lewei3 (AUTHOR), Gale, Robert Peter4 (AUTHOR), Xia, Zhongjun1 (AUTHOR) xiazhj@sysucc.org.cn, Liang, Yang1 (AUTHOR) liangyang@sysucc.org.cn, Wang, Hua1 (AUTHOR) wanghua@sysucc.org.cn
Zdroj: Hematology. Dec2024, Vol. 29 Issue 1, p1-6. 6p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje